BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hod T, Ben-David A, Olmer L, Scott N, Ghinea R, Mor E, Levy I, Indenbaum V, Lustig Y, Grossman E, Rahav G. BNT162b2 Third Booster Dose Significantly Increases the Humoral Response Assessed by Both RBD IgG and Neutralizing Antibodies in Renal Transplant Recipients. Transpl Int 2022;35:10239. [PMID: 35387393 DOI: 10.3389/ti.2022.10239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Malik SA, Modarage K, Goggolidou P. A systematic review assessing the effectiveness of COVID-19 mRNA vaccines in chronic kidney disease (CKD) individuals. F1000Res 2022;11:909. [DOI: 10.12688/f1000research.122820.1] [Reference Citation Analysis]
2 Kontopoulou K, Nakas CT, Belai C, Papazisis G. Antibody Titers After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in immunocompromised adults in Greece: is a fourth dose necessary? J Med Virol 2022. [PMID: 35739059 DOI: 10.1002/jmv.27954] [Reference Citation Analysis]